Our transcatheter aortic valve implantation (TAVI) program offers a possible alternative to open heart surgery for patients with severe, symptomatic aortic stenosis who are high risk for surgery or who are inoperable.
This document discusses transcatheter aortic valve implantation (TAVI) for treating severe aortic stenosis. It summarizes several key trials that demonstrated the safety and effectiveness of TAVI compared to surgical aortic valve replacement. The PARTNER trials showed TAVI to be non-inferior to surgery in reducing mortality, while being associated with lower risks of bleeding, stroke, and repeat hospitalization. Subsequent trials like the CoreValve US Pivotal Trial and CHOICE trial reinforced TAVI as a standard treatment for high-risk surgical patients with aortic stenosis.
This document discusses transcatheter aortic valve implantation (TAVI) and the risk of cerebral embolization during the procedure. TAVI is a minimally invasive procedure used to treat aortic stenosis that is growing rapidly worldwide. However, TAVI is associated with a risk of stroke between 2-4% within 30 days after the procedure due to cerebral embolization of debris. The document proposes developing a solution to reduce the risk of cerebral embolization and associated strokes during TAVI by at least 50%. It outlines criteria for an effective solution, competitive advantages over existing devices, hurdles to overcome, as well as the large market potential given the growth of TAVI procedures globally.
Dr. John Frederik presents "CTSA Summit TAVR" at the March 4 -6, 2016 Cardiac and Thoracic Surgery Associates, Cardiovascular Summit at The Westin Riverfront Resort and Spa.
Tavi,Transcatheter Aortic Valve Replacement, TAVI,TAVR,Dr.Hasan Mahmud
Transcatheter aortic valve implantation (TAVI) has been developed as an alternative to surgical aortic valve replacement for high-risk patients. TAVI involves threading a collapsible valve through blood vessels and implanting it to replace the diseased valve. Over 30,000 high-risk patients with severe aortic stenosis have undergone TAVI, based on evidence from studies showing it is safer than surgery for this group. TAVI indications may expand as longer-term data on outcomes becomes available and the procedure requires a multidisciplinary team approach and dedicated training.
Transcatheter Aortic Valve Replacement (TAVR): Established and Emerging Indic...Allina Health
By Paul Sorajja, MD. The efficacy and safety of transcatheter valve replacement in high-risk, non-operable patients is leading to new valve therapy options for a broader pateint population. "The options we have today to fix problems without opening the chest would have been unimaginable 10 years ago."
TAVI has become an accepted treatment for severe aortic stenosis, especially in high-risk patients. The PARTNER trial showed non-inferiority of TAVI compared to surgery in high-risk patients, with lower rates of major bleeding and new onset atrial fibrillation for TAVI. A team approach including cardiologists and cardiac surgeons is recommended for optimal patient outcomes with TAVI.
The document provides an overview of transcatheter aortic valve implantation (TAVI), including a brief history of its development, descriptions of the Edwards Sapien valve and delivery systems, approaches for TAVI, and complications. It also discusses patient screening and risk stratification, as well as newer valve devices that are being developed.
This document provides an overview of trans-catheter aortic valve implantation (TAVI). It discusses the indications for TAVI including symptomatic severe aortic stenosis in high-risk surgical patients. The pre-procedural workup involves imaging to assess anatomy and risk. The procedure involves accessing the femoral or other arteries and deploying a balloon-expandable or self-expanding bioprosthetic valve. Complications include conduction abnormalities, paravalvular regurgitation, and hypotension. Two clinical cases are presented of high-risk patients undergoing TAVI.
This document discusses transcatheter aortic valve implantation (TAVI) for treating severe aortic stenosis. It summarizes several key trials that demonstrated the safety and effectiveness of TAVI compared to surgical aortic valve replacement. The PARTNER trials showed TAVI to be non-inferior to surgery in reducing mortality, while being associated with lower risks of bleeding, stroke, and repeat hospitalization. Subsequent trials like the CoreValve US Pivotal Trial and CHOICE trial reinforced TAVI as a standard treatment for high-risk surgical patients with aortic stenosis.
This document discusses transcatheter aortic valve implantation (TAVI) and the risk of cerebral embolization during the procedure. TAVI is a minimally invasive procedure used to treat aortic stenosis that is growing rapidly worldwide. However, TAVI is associated with a risk of stroke between 2-4% within 30 days after the procedure due to cerebral embolization of debris. The document proposes developing a solution to reduce the risk of cerebral embolization and associated strokes during TAVI by at least 50%. It outlines criteria for an effective solution, competitive advantages over existing devices, hurdles to overcome, as well as the large market potential given the growth of TAVI procedures globally.
Dr. John Frederik presents "CTSA Summit TAVR" at the March 4 -6, 2016 Cardiac and Thoracic Surgery Associates, Cardiovascular Summit at The Westin Riverfront Resort and Spa.
Tavi,Transcatheter Aortic Valve Replacement, TAVI,TAVR,Dr.Hasan Mahmud
Transcatheter aortic valve implantation (TAVI) has been developed as an alternative to surgical aortic valve replacement for high-risk patients. TAVI involves threading a collapsible valve through blood vessels and implanting it to replace the diseased valve. Over 30,000 high-risk patients with severe aortic stenosis have undergone TAVI, based on evidence from studies showing it is safer than surgery for this group. TAVI indications may expand as longer-term data on outcomes becomes available and the procedure requires a multidisciplinary team approach and dedicated training.
Transcatheter Aortic Valve Replacement (TAVR): Established and Emerging Indic...Allina Health
By Paul Sorajja, MD. The efficacy and safety of transcatheter valve replacement in high-risk, non-operable patients is leading to new valve therapy options for a broader pateint population. "The options we have today to fix problems without opening the chest would have been unimaginable 10 years ago."
TAVI has become an accepted treatment for severe aortic stenosis, especially in high-risk patients. The PARTNER trial showed non-inferiority of TAVI compared to surgery in high-risk patients, with lower rates of major bleeding and new onset atrial fibrillation for TAVI. A team approach including cardiologists and cardiac surgeons is recommended for optimal patient outcomes with TAVI.
The document provides an overview of transcatheter aortic valve implantation (TAVI), including a brief history of its development, descriptions of the Edwards Sapien valve and delivery systems, approaches for TAVI, and complications. It also discusses patient screening and risk stratification, as well as newer valve devices that are being developed.
This document provides an overview of trans-catheter aortic valve implantation (TAVI). It discusses the indications for TAVI including symptomatic severe aortic stenosis in high-risk surgical patients. The pre-procedural workup involves imaging to assess anatomy and risk. The procedure involves accessing the femoral or other arteries and deploying a balloon-expandable or self-expanding bioprosthetic valve. Complications include conduction abnormalities, paravalvular regurgitation, and hypotension. Two clinical cases are presented of high-risk patients undergoing TAVI.
Tavi is the evidence catching up with realityNagesh Waghmare
1. Two large European registries showed TAVI to have high technical success rates of 98-99% and 30-day mortality of 12% for inoperable patients, demonstrating its safety and efficacy in real-world settings.
2. The PARTNER Trial Cohort B was the first randomized controlled trial of TAVI versus standard therapy and showed TAVI to be superior to standard therapy in reducing 1-year mortality for inoperable patients.
3. The PARTNER Trial Cohort A randomized high surgical risk patients to TAVI or SAVR and found non-inferiority of TAVI to SAVR with lower rates of bleeding, atrial fibrillation, and shorter hospital stays for TAVI
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low...Shadab Ahmad
The role of transcatheter aortic valve replacement (TAVR) in the treatment of patients with severe, symptomatic aortic stenosis has evolved on the basis of evidence from clinical trials.
Previous randomized trials of TAVR with both balloon-expandable valves and self-expanding valves showed that, in patients who were at intermediate or high risk for death with surgery, TAVR was either superior or noninferior to standard therapies, including surgical aortic-valve replacement.
However, most patients with severe aortic stenosis are at low surgical risk, and there is insufficient evidence regarding the comparison of TAVR with surgery in such patients.
Peter Hansen is a Cardiologist with a particular interest in Transcatheter Aortic Valve Implantation. This talk is all about TAVI's and imaging used to assess them. You may be seeing a lot more TAVI's so this superb insight from an expert is invaluable.
The document discusses transcatheter therapy for mitral regurgitation. It describes the anatomy of the mitral valve and causes of mitral regurgitation. Surgical repair or replacement is the standard treatment but some high-risk patients are not candidates. The MitraClip procedure is described which uses a percutaneous clip to grasp the leaflets and reduce regurgitation as a less invasive alternative for selected patients. Effectiveness has been demonstrated in clinical trials but long-term outcomes are still being evaluated.
1. Transcatheter aortic valve implantation (TAVI) was first performed in humans in 2002 in France using a bovine pericardium valve.
2. There are several vascular access approaches for TAVI, including transfemoral, transapical, transaortic, and subclavian approaches.
3. A 2013 feasibility study of a new device for TAVI in patients with aortic insufficiency reported successful deployment in all four patients with no deaths at 30 days and improved aortic insufficiency in all patients.
This document provides guidelines for obtaining optimal views and measurements during a transesophageal echocardiogram (TEE) for mitral valve repair. It recommends obtaining 0, 60-90, 110-130 degree views of the mitral valve as well as additional views such as of the pulmonary veins and 3D imaging. It describes how to obtain measurements of flail gap, flail width, and vertical coaptation length for degenerative and functional mitral regurgitation. The document also provides indications for use and safety information for the MitraClip device intended for reducing mitral regurgitation in high-risk surgical patients.
This document discusses the use of transradial artery (TRA) access for structural heart interventions. It provides reasons for and against TRA, as well as specific examples where TRA is beneficial. Some key benefits of TRA include avoiding bleeding complications, keeping large venous and arterial sheaths separate, and providing hemodynamic monitoring and support during complex procedures. Specific cases where TRA is useful include left atrial appendage occlusion, MitraClip procedures, coronary arteriovenous fistula closure, coarctation of the aorta repair, and post-myocardial infarction ventricular septal defect closure. TRA can improve visualization, device positioning and manipulation, and allow for pressure monitoring during challenging structural heart interventions.
The document describes a case where a 81 year old woman with severe aortic stenosis and comorbidities underwent a transaortic aortic valve implantation (TA-AVI) through an upper ministernotomy approach. Key steps included making a 5cm J-shaped incision, inserting an 8Fr sheath through the aorta, crossing the native valve with a wire, inserting a delivery system, performing balloon aortic valvuloplasty, and releasing the new valve. The procedure was successful with normal valve function and recovery. The upper ministernotomy provides an alternative access for patients not suitable for transfemoral approaches and avoids arch crossing.
This document provides information on transradial catheterization procedures. It defines ideal candidates for transradial catheterization and lists contraindications. It describes the pre-procedure assessment including checking for dual circulation in the hand. The patient setup is also outlined, including positioning the arm and wrist, applying pulse oximetry, and preparing equipment like sheaths and catheters. Post-procedure care instructions including use of a TR band, monitoring the access site, and discharge instructions are provided.
Aortic Valve Stenosis with low EF : TAVR versus Replacementdrucsamal
1) Patients with low ejection fraction (EF < 50%) and severe aortic stenosis who undergo transcatheter aortic valve replacement (TAVI) have similar mortality at 1 year compared to those with higher EF, despite being higher risk.
2) TAVI is associated with significant improvements in EF, symptoms, and quality of life over 1 year in patients with very low EF (≤30%). However, mortality remains higher compared to those with EF >30%.
3) Both TAVI and surgical aortic valve replacement (SAVR) are associated with improvements in EF at 3 months in propensity matched populations with low EF. Short term outcomes are similar, but TAVI is associated with more pacemakers
DETAILS OF EVIDENCE TAVI FROM ITS EXISTENCE IN INTERVENTIONAL CARDIOLOGY TO THE SURTAVI REGISTRY ..AS AN OPTION FROM HIGH RISK UNOPERABLE PATIENTS TO INTERMEDIATE AND LOW RISK PATIENTS
This document discusses factors affecting survival after mitral valve replacement, specifically the impact of prosthesis-patient mismatch (PPM). It presents results from a study of 765 patients who underwent mitral valve replacement. The study found that PPM was less common with mechanical valves and more common in older patients, women, and those with comorbidities. PPM, especially severe PPM, was associated with higher operative mortality and worse late survival outcomes. PPM also contributed to persistent pulmonary hypertension and tricuspid regurgitation after surgery. The document recommends techniques to prevent severe PPM, such as using a 3-step protocol to select appropriately sized valves.
- The document discusses reasons for failure of thoracic endovascular aortic repair (TEVAR) and outcomes of secondary surgical interventions.
- The main reasons for TEVAR failure identified are type I endoleaks, persistent false lumen perfusion in chronic dissection, retrograde dissection, and graft infection.
- Most secondary surgical interventions involved total arch replacement or descending aorta replacement to address failures. Outcomes were mixed, with 13.5% mortality and many requiring additional operations later. Proper patient and graft selection can help reduce the need for open conversion after TEVAR failure.
Echocardiography plays an important role in the care of patients undergoing transcatheter aortic valve implantation (TAVI). Pre-procedurally, echocardiography is used to confirm the severity of aortic stenosis, assess the aortic annulus size, exclude contraindications like left ventricular thrombus, and help determine the optimal access route. During TAVI, echocardiography guides valve selection and positioning, identifies complications, and can help address issues like paravalvular regurgitation. Post-procedure, echocardiography is crucial for long-term monitoring of valve function and the detection of any late complications.
This document summarizes the results of a randomized controlled trial comparing transcatheter aortic valve replacement (TAVR) to surgical aortic valve replacement (SAVR) in patients at low surgical risk. The trial found that TAVR was superior to SAVR in reducing the composite outcome of death from any cause, stroke, or rehospitalization at 1 year. TAVR was also associated with lower rates of mortality at 30 days, life-threatening bleeding, and shorter hospital stays compared to SAVR. However, TAVR was associated with higher rates of new-onset left bundle branch block and mild paravalvular regurgitation compared to SAVR.
AHA Valvular guidelines 2020, What is new?AhmedElBorae1
The document summarizes key changes in the 2020 American Heart Association valvular heart disease guidelines compared to previous versions. Some notable changes include a lower threshold for intervention in aortic and mitral regurgitation to prevent ventricular dysfunction, expanded recommendations for mitral valve repair with transcatheter edge-to-edge repair for primary and secondary mitral regurgitation, consideration of early intervention for severe symptomatic isolated tricuspid regurgitation, and recognition of catheter-based treatments like valve-in-valve as reasonable options for treating prosthetic valve dysfunction in selected patients. The presentation also reviews guidelines on infective endocarditis prophylaxis, medical management of chronic regurgitation, and decision-making factors for biopropro
J. cleveland destinatin lvad therapy are we there yetAlysia Smith
Dr. Joesph Cleveland, MD presents "Destination LVAD Therapy-Are We There Yet" at the March 4 -6, 2016 Cardiac and Thoracic Surgery Associates, Cardiovascular Summit at The Westin Riverfront Resort and Spa.
This document provides information about transcatheter aortic valve replacement (TAVR) to patients with severe aortic stenosis. It describes how the heart works, what aortic stenosis is, and treatment options. The main treatment options discussed are open-heart surgery and TAVR. TAVR involves inserting a new valve via the femoral artery or directly through the chest. The document outlines the TAVR procedure step-by-step and discusses risks. It also provides data on clinical trials that have evaluated the safety and effectiveness of TAVR.
Coronary artery disease (CAD) occurs when the arteries that supply blood to the heart become narrowed due to plaque buildup within the arteries over many years. This reduces blood flow and oxygen to the heart muscle. CAD is diagnosed using tests like electrocardiograms, stress tests, echocardiograms, and heart scans. Treatment options include medications to improve blood flow, angioplasty to widen narrowed arteries using a balloon catheter, stents to prop open the arteries, or atherectomy using a tiny drill to remove plaque. Lifestyle changes like a healthy diet, exercise, weight control, and managing conditions like diabetes and high blood pressure can help prevent and manage CAD.
Tavi is the evidence catching up with realityNagesh Waghmare
1. Two large European registries showed TAVI to have high technical success rates of 98-99% and 30-day mortality of 12% for inoperable patients, demonstrating its safety and efficacy in real-world settings.
2. The PARTNER Trial Cohort B was the first randomized controlled trial of TAVI versus standard therapy and showed TAVI to be superior to standard therapy in reducing 1-year mortality for inoperable patients.
3. The PARTNER Trial Cohort A randomized high surgical risk patients to TAVI or SAVR and found non-inferiority of TAVI to SAVR with lower rates of bleeding, atrial fibrillation, and shorter hospital stays for TAVI
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low...Shadab Ahmad
The role of transcatheter aortic valve replacement (TAVR) in the treatment of patients with severe, symptomatic aortic stenosis has evolved on the basis of evidence from clinical trials.
Previous randomized trials of TAVR with both balloon-expandable valves and self-expanding valves showed that, in patients who were at intermediate or high risk for death with surgery, TAVR was either superior or noninferior to standard therapies, including surgical aortic-valve replacement.
However, most patients with severe aortic stenosis are at low surgical risk, and there is insufficient evidence regarding the comparison of TAVR with surgery in such patients.
Peter Hansen is a Cardiologist with a particular interest in Transcatheter Aortic Valve Implantation. This talk is all about TAVI's and imaging used to assess them. You may be seeing a lot more TAVI's so this superb insight from an expert is invaluable.
The document discusses transcatheter therapy for mitral regurgitation. It describes the anatomy of the mitral valve and causes of mitral regurgitation. Surgical repair or replacement is the standard treatment but some high-risk patients are not candidates. The MitraClip procedure is described which uses a percutaneous clip to grasp the leaflets and reduce regurgitation as a less invasive alternative for selected patients. Effectiveness has been demonstrated in clinical trials but long-term outcomes are still being evaluated.
1. Transcatheter aortic valve implantation (TAVI) was first performed in humans in 2002 in France using a bovine pericardium valve.
2. There are several vascular access approaches for TAVI, including transfemoral, transapical, transaortic, and subclavian approaches.
3. A 2013 feasibility study of a new device for TAVI in patients with aortic insufficiency reported successful deployment in all four patients with no deaths at 30 days and improved aortic insufficiency in all patients.
This document provides guidelines for obtaining optimal views and measurements during a transesophageal echocardiogram (TEE) for mitral valve repair. It recommends obtaining 0, 60-90, 110-130 degree views of the mitral valve as well as additional views such as of the pulmonary veins and 3D imaging. It describes how to obtain measurements of flail gap, flail width, and vertical coaptation length for degenerative and functional mitral regurgitation. The document also provides indications for use and safety information for the MitraClip device intended for reducing mitral regurgitation in high-risk surgical patients.
This document discusses the use of transradial artery (TRA) access for structural heart interventions. It provides reasons for and against TRA, as well as specific examples where TRA is beneficial. Some key benefits of TRA include avoiding bleeding complications, keeping large venous and arterial sheaths separate, and providing hemodynamic monitoring and support during complex procedures. Specific cases where TRA is useful include left atrial appendage occlusion, MitraClip procedures, coronary arteriovenous fistula closure, coarctation of the aorta repair, and post-myocardial infarction ventricular septal defect closure. TRA can improve visualization, device positioning and manipulation, and allow for pressure monitoring during challenging structural heart interventions.
The document describes a case where a 81 year old woman with severe aortic stenosis and comorbidities underwent a transaortic aortic valve implantation (TA-AVI) through an upper ministernotomy approach. Key steps included making a 5cm J-shaped incision, inserting an 8Fr sheath through the aorta, crossing the native valve with a wire, inserting a delivery system, performing balloon aortic valvuloplasty, and releasing the new valve. The procedure was successful with normal valve function and recovery. The upper ministernotomy provides an alternative access for patients not suitable for transfemoral approaches and avoids arch crossing.
This document provides information on transradial catheterization procedures. It defines ideal candidates for transradial catheterization and lists contraindications. It describes the pre-procedure assessment including checking for dual circulation in the hand. The patient setup is also outlined, including positioning the arm and wrist, applying pulse oximetry, and preparing equipment like sheaths and catheters. Post-procedure care instructions including use of a TR band, monitoring the access site, and discharge instructions are provided.
Aortic Valve Stenosis with low EF : TAVR versus Replacementdrucsamal
1) Patients with low ejection fraction (EF < 50%) and severe aortic stenosis who undergo transcatheter aortic valve replacement (TAVI) have similar mortality at 1 year compared to those with higher EF, despite being higher risk.
2) TAVI is associated with significant improvements in EF, symptoms, and quality of life over 1 year in patients with very low EF (≤30%). However, mortality remains higher compared to those with EF >30%.
3) Both TAVI and surgical aortic valve replacement (SAVR) are associated with improvements in EF at 3 months in propensity matched populations with low EF. Short term outcomes are similar, but TAVI is associated with more pacemakers
DETAILS OF EVIDENCE TAVI FROM ITS EXISTENCE IN INTERVENTIONAL CARDIOLOGY TO THE SURTAVI REGISTRY ..AS AN OPTION FROM HIGH RISK UNOPERABLE PATIENTS TO INTERMEDIATE AND LOW RISK PATIENTS
This document discusses factors affecting survival after mitral valve replacement, specifically the impact of prosthesis-patient mismatch (PPM). It presents results from a study of 765 patients who underwent mitral valve replacement. The study found that PPM was less common with mechanical valves and more common in older patients, women, and those with comorbidities. PPM, especially severe PPM, was associated with higher operative mortality and worse late survival outcomes. PPM also contributed to persistent pulmonary hypertension and tricuspid regurgitation after surgery. The document recommends techniques to prevent severe PPM, such as using a 3-step protocol to select appropriately sized valves.
- The document discusses reasons for failure of thoracic endovascular aortic repair (TEVAR) and outcomes of secondary surgical interventions.
- The main reasons for TEVAR failure identified are type I endoleaks, persistent false lumen perfusion in chronic dissection, retrograde dissection, and graft infection.
- Most secondary surgical interventions involved total arch replacement or descending aorta replacement to address failures. Outcomes were mixed, with 13.5% mortality and many requiring additional operations later. Proper patient and graft selection can help reduce the need for open conversion after TEVAR failure.
Echocardiography plays an important role in the care of patients undergoing transcatheter aortic valve implantation (TAVI). Pre-procedurally, echocardiography is used to confirm the severity of aortic stenosis, assess the aortic annulus size, exclude contraindications like left ventricular thrombus, and help determine the optimal access route. During TAVI, echocardiography guides valve selection and positioning, identifies complications, and can help address issues like paravalvular regurgitation. Post-procedure, echocardiography is crucial for long-term monitoring of valve function and the detection of any late complications.
This document summarizes the results of a randomized controlled trial comparing transcatheter aortic valve replacement (TAVR) to surgical aortic valve replacement (SAVR) in patients at low surgical risk. The trial found that TAVR was superior to SAVR in reducing the composite outcome of death from any cause, stroke, or rehospitalization at 1 year. TAVR was also associated with lower rates of mortality at 30 days, life-threatening bleeding, and shorter hospital stays compared to SAVR. However, TAVR was associated with higher rates of new-onset left bundle branch block and mild paravalvular regurgitation compared to SAVR.
AHA Valvular guidelines 2020, What is new?AhmedElBorae1
The document summarizes key changes in the 2020 American Heart Association valvular heart disease guidelines compared to previous versions. Some notable changes include a lower threshold for intervention in aortic and mitral regurgitation to prevent ventricular dysfunction, expanded recommendations for mitral valve repair with transcatheter edge-to-edge repair for primary and secondary mitral regurgitation, consideration of early intervention for severe symptomatic isolated tricuspid regurgitation, and recognition of catheter-based treatments like valve-in-valve as reasonable options for treating prosthetic valve dysfunction in selected patients. The presentation also reviews guidelines on infective endocarditis prophylaxis, medical management of chronic regurgitation, and decision-making factors for biopropro
J. cleveland destinatin lvad therapy are we there yetAlysia Smith
Dr. Joesph Cleveland, MD presents "Destination LVAD Therapy-Are We There Yet" at the March 4 -6, 2016 Cardiac and Thoracic Surgery Associates, Cardiovascular Summit at The Westin Riverfront Resort and Spa.
This document provides information about transcatheter aortic valve replacement (TAVR) to patients with severe aortic stenosis. It describes how the heart works, what aortic stenosis is, and treatment options. The main treatment options discussed are open-heart surgery and TAVR. TAVR involves inserting a new valve via the femoral artery or directly through the chest. The document outlines the TAVR procedure step-by-step and discusses risks. It also provides data on clinical trials that have evaluated the safety and effectiveness of TAVR.
Coronary artery disease (CAD) occurs when the arteries that supply blood to the heart become narrowed due to plaque buildup within the arteries over many years. This reduces blood flow and oxygen to the heart muscle. CAD is diagnosed using tests like electrocardiograms, stress tests, echocardiograms, and heart scans. Treatment options include medications to improve blood flow, angioplasty to widen narrowed arteries using a balloon catheter, stents to prop open the arteries, or atherectomy using a tiny drill to remove plaque. Lifestyle changes like a healthy diet, exercise, weight control, and managing conditions like diabetes and high blood pressure can help prevent and manage CAD.
Coronary artery disease (CAD) occurs when the arteries that supply blood to the heart become narrowed due to plaque buildup within the arteries over many years. This reduces blood flow and oxygen delivery to the heart muscle. CAD has certain unmodifiable risk factors like age, gender and family history, but also modifiable ones like high blood pressure, high cholesterol, diabetes, obesity, physical inactivity and smoking. Diagnostic tests like electrocardiograms, stress tests, echocardiograms and heart scans can detect CAD. Cardiac catheterization involves threading a catheter into the heart to take pictures of the coronary arteries and measure pressure. Angioplasty and stenting can then be used to open blocked arteries and improve blood
"Dr. Gautam Swaroop is a promising Interventional Cardiologist from Lucknow extending catheter based treatment for structural heart diseases. Practicing since 2015, Dr. Swaroop’s professional affiliation lies with Lucknow–based Vivekananda Polyclinic & Institute of Medical Sciences and Hari Spandan clinic, practicing during the morning and evening hours respectively. On completion of MBBS, Dr. Swaroop trained in MD (Medicine) and DM (Cardiology) finalizing his education from institutes such as MLB Medical College, Jhansi and KGMU, Lucknow. Dr. Swaroop excelled in his MBBS examinations bagging several Gold medals for the same. Currently working in Sahara Hospital, Lucknow and he has worked for Vivekananda hospital."
Mitral valve repair is a procedure to treat narrowing or leakage of the mitral valve.
In this procedure damaged mitral valve is replaced by either a mechanical or bioprosthetic valve.
In heart valve disease, one or more of the valves in your heart doesn't work properly.
Your heart has four valves that keep blood flowing in the correct direction. In some cases, one or more of the valves don't open or close properly. This can cause the blood flow through your heart to your body to be disrupted.
Your heart valve disease treatment depends on the heart valve affected and the type and severity of the valve disease. Sometimes heart valve disease requires surgery to repair or replace the heart valve.Your heart has four valves that keep blood flowing in the correct direction. These valves include the mitral valve, tricuspid valve, pulmonary valve and aortic valve. Each valve has flaps (leaflets or cusps) that open and close once during each heartbeat. Sometimes, the valves don't open or close properly, disrupting the blood flow through your heart to your body.
Heart valve disease may be present at birth (congenital). It can also occur in adults due to many causes and conditions, such as infections and other heart conditions.
Heart valve problems may include:
Regurgitation. In this condition, the valve flaps don't close properly, causing blood to leak backward in your heart. This commonly occurs due to valve flaps bulging back, a condition called prolapse.
Stenosis. In valve stenosis, the valve flaps become thick or stiff, and they may fuse together. This results in a narrowed valve opening and reduced blood flow through the valve.
Atresia. In this condition, the valve isn't formed, and a solid sheet of tissue blocks the blood flow between the heart chambers.Several factors can increase your risk of heart valve disease, including:
Older age
History of certain infections that can affect the heart
History of certain forms of heart disease or heart attack
High blood pressure, high cholesterol, diabetes and other heart disease risk factors
Heart conditions present at birth (congenital heart disease)Heart valve disease can cause many complications, including:
Heart failure
Stroke
Blood clots
Heart rhythm abnormalities
Death
Institute of Cardiac Science and Research (Cardiology - AIG Hospitals)AIG Hospitals
AIG Institute of Cardiac Sciences offers comprehensive cardiac care services supported by the latest technology, advanced infrastructure, and expertise in
treating rare and complex heart
conditions.
The multidisciplinary approach to cardiac care involves renowned senior cardiologists, electrophysiologists, cardiac
surgeons, critical care intensivists,
anesthetists, cardiac technicians, and nurses.
Our cardiologists are leaders in research, diagnosis, and therapies for people with heart conditions.
Common Heart Diseases:
Heart attack is usually what strikes most people when they think of heart disease. However, there are a number of diseases that affect the heart or blood vessels of a
person. Some of them are mentioned below:
Coronary Artery Disease (CAD)/Ischemic heart disease
Arrhythmias and Palpitations
Inflammatory heart disease
Hypertensive heart disease
Heart failure
Valvular heart disease
Rheumatic heart disease
Causes of Heart Diseases:
In order to prevent heart diseases, controlling various risk factors that cause heart problems is essential.
Factors that cause heart diseases are:
Abnormal blood cholesterol (dyslipidemia)
High blood pressure (hypertension)
Smoking and other forms of tobacco use
Diabetes
Being overweight or obese
Physical inactivity
Age over 55 (for men) or 65 (for women)
Family history of CAD
Psychological stress
Who needs Heart Surgery?
People need heart surgery for different reasons. The most common reasons are
Coronary Artery Disease
Damaged Heart Valves
Enlarged Aortic artery
Understanding the facts about Coronary Angiography and Angioplasty
Cardiologists at AIG Hospitals have expertise in using latest stent
technology such Drug Eluting Stent and Bioabsorbable stents
Coronary artery bypass grafting (CABG)
Coronary artery bypass grafting is a type of surgery that
improves blood ow to the heart. This surgery is used to treat
coronary artery disease (CAD). CABG also is known as bypass
surgery, coronary artery bypass surgery, and open-heart surgery.
Coronary artery bypass grafting (CABG) involves taking a vein or
artery from another part of the body, usually the chest or leg, and
attaching it to the coronary artery above and below the
narrowed area or blockage. This replacement vein or artery is
called a graft and allows blood to bypass the narrowing or block-
age, improving blood supply to the heart muscle.
Common medical tests that are performed for the diagnosis of a heart condition
ECG (Electrocardiogram)
Blood tests, including tests to see whether cardiac enzymes are high, can be a sign of heart damage.
Cardiology & Cardiothoracic Procedures performed here at AIG Hospitals:
Non-invasive Cardiology
ECG
2D- Echo, Dobutamine stress echo
TMT / Cardiac stress test
Ambulatory Blood Pressure
Nuclear stress test
Holter Monitoring
CT Angiogram
Cardiac MRI
Pulmonary Function Test (PFT)
X-ray Chest
PET-CT Scan
Essential Facts to Understand Before Undergoing a Transcatheter Aortic Valve ...samsinggh
Transcatheter Aortic Valve Implantation (TAVI) represents a less invasive surgical technique utilized for the treatment of aortic valve stenosis, a medical condition characterized by the narrowing of the aortic valve, causing a hindrance to blood flow from the heart to the body's other parts. If you have received a recommendation for TAVI, you might possess numerous inquiries and questions. This article will furnish you with all information regarding the transcatheter aortic valve implantation procedure.
I am a Neurosurgeon with advanced training in Interventional vascular Neurosurgery(FINR) from Zurich, Switzerland, and FMINS-Fellowship in minimally invasive and Endoscopic Neurosurgery from Germany.
I am presently working in Columbia asia hospitals, Bangalore.
My areas of interest are Vascular Neurosurgery, Stroke specialist, interventional neuroradiology, Endoscopic and minimally invasive Neurosurgery, Endoscopic spine surgery.
valve replacement and reconstruction.pptxEDWINjose43
This document discusses valve reconstruction and replacement procedures for the aortic and mitral valves. It begins with an introduction to cardiac valve surgery and relevant anatomy. It then covers the history of valve surgery and discusses techniques for valve reconstruction including commissurotomy, annuloplasty, chordoplasty, and balloon valvuloplasty. Indications and surgical procedures for reconstructing specifically the aortic and mitral valves are described. The document also briefly discusses tricuspid valve anatomy, indications for surgery, and repair techniques. It concludes with a short definition of valve replacement.
Cardiovascular surgery involves repairing or improving cardiac issues that cannot be treated with drugs or minor procedures. The goal is often to reduce symptoms and improve quality of life, rather than completely resolving the problem. Common procedures include vascular bypass surgery to redirect blood flow around blockages, heart valve surgery to repair or replace diseased valves, and heart transplants to replace a disabled heart. Pacemakers are also used to treat irregular or slow heart rhythms through electrical signals. These surgeries aim to treat issues like coronary artery disease, heart failure, and arrhythmias.
The goal of our atrial fibrillation team is to improve
your health by reducing symptoms, preventing
complications, improving quality of life and
preventing long-term illness.
This document discusses valvular heart diseases or valvulopathies. It defines valvular diseases as diseases of the heart valves, which allow blood to flow between the heart's chambers and out to the arteries. The four valves that can be affected are the mitral, aortic, pulmonary and tricuspid valves. Common causes include infection, aging, and previously, rheumatic fever. Symptoms, diagnosis, and treatment options are described for the main types of valvular diseases - aortic stenosis, aortic insufficiency, mitral stenosis, and mitral insufficiency. Prevention focuses on treating underlying causes early and a healthy lifestyle, as well as antibiotic prophylaxis for those with valv
Medical terminology referred to as a Ventricular Septal Defect (VSD) or an Atrial Septal Defect (ASD). In terms of Ventricular Septal Defect (VSD), a wall between the main pumping chambers of the heart (the ventricles) is abnormally opened. And in Atrial Septal Defect (ASD) terms, there is a hole in the wall between the two upper chambers of the heart (the atria). This condition is congenital means present at birth.
Open heart surgery involves opening the chest wall and directly operating on the heart muscles, valves or arteries. It requires a heart-lung machine. Closed heart surgery works on structures outside the heart without a heart-lung machine. Common valvular heart surgeries discussed include mitral valve stenosis and regurgitation repairs/replacements, aortic valve stenosis and regurgitation repairs/replacements, and tricuspid valve regurgitation repairs/replacements. Signs, causes, evaluations and treatments are provided for each procedure.
The document discusses the TAVR (transcatheter aortic valve replacement) procedure, which is a minimally invasive alternative to open-heart surgery used to replace the aortic valve in patients considered too high risk for open-heart surgery. The TAVR procedure involves inserting an artificial valve through the femoral or apical artery using a catheter. Potential complications include stroke, death, and bleeding issues. Physical therapy implications include screening patients who will be on lifelong aspirin therapy for risk of bleeding complications and addressing mobility issues common in the elderly patient population eligible for TAVR.
Valvulopathies are diseases that affect the heart valves, preventing their proper opening and closing. The four heart valves - mitral, aortic, pulmonary and tricuspid - can all be affected. The most common causes are rheumatic fever, aging and degeneration. Symptoms depend on the severity of the valve disease but often include shortness of breath and chest pain. Diagnosis is made through echocardiogram. Treatment options include valve replacement surgery using artificial valves or valve repair procedures like valvuloplasty. Preventive measures include treating underlying causes early and maintaining a healthy lifestyle.
The heart is the vital organ in the human being. A healthy heart is a key to healthy living. India is the ideal destination for heart surgery because of cost-effectiveness and the efficiency of healthcare professionals in the surgical procedures.
Surgical procedures are well practiced and the success rate in the journey is very high. When compared to the developed countries like the USA, UK, Japan and Singapore the factors like cost-saving and low waiting line makes India a perfect destination for treatment of diseases related to heart.
Varicose veins are swollen, twisted veins that are typically caused by a malfunctioning deeper vein called the saphenous vein. Doctors use ultrasound imaging to evaluate the source of varicose veins and may recommend treatment to correct the underlying issue, such as surgery to repair the saphenous vein. Surgery involves eliminating blood flow in the saphenous vein using heat energy and then removing individual varicose veins through small incisions. The procedure is performed in an office setting using local anesthesia and patients can return to light activity right away with compression stockings.
The document provides an overview of several interventional procedures for treating valve diseases, including percutaneous aortic valve replacement, percutaneous mitral valve repair, percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), cardiac devices like implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT), and artificial hearts. Key procedures discussed include replacing the aortic valve through a catheter in the femoral artery, repairing the mitral valve with a small metal clip, and implanting devices like ICDs, CRT pacemakers, and temporary artificial hearts.
Similar to Transcatheter Aortic Valve Implantation (TAVI) (20)
Karen Luchini's life was saved twice by UMass Memorial - first after sustaining life-threatening injuries in a cycling crash in 2011, and then in 2013 when she was diagnosed with and treated for leukemia. Darlene Renaud expresses gratitude to the doctors and nurses at UMass Memorial for saving her life after being diagnosed with and treated for lung cancer in 2014. Richard Townsend feels that the doctors and medical professionals at UMass Memorial saved his life by treating his prostate cancer through radiation therapy.
This document provides 28 challenges or tips for improving heart health, including knowing your risk factors for heart disease, making healthy lifestyle changes at any age, learning CPR, healthy snacking, getting enough sleep, exercising regularly, dining out heart healthy, and making long-lasting changes to one's lifestyle and diet for better heart health.
The document is a calendar for February 2015 from UMass Memorial Heart & Vascular Center that provides information on heart health topics for each day of the month. It includes articles on risk factors for heart disease, lifestyle changes to reduce risk, CPR and how it can save lives, healthy snacking guidelines, calculating BMI and waist measurement, making appointments with cardiologists, using mobile apps and patient portals, heart disease in children and young adults, heart-healthy dining options, monitoring blood pressure, risks of smoking, moderating alcohol, coping with chronic heart conditions, exercise and physical activity, attending seminars, preventing and treating atrial fibrillation, and adopting long-term healthy lifestyle changes.
The document summarizes several ideas submitted to a hospital's idea system. One idea involves radiation oncology nurses placing notes in patients' electronic records to improve communication about patient check-ins. Another addresses no-shows in a pediatric office by calling patients to confirm appointments, opening slots for urgent visits. A third creates a centralized therapist scheduling system. And a final initiative encourages handwashing among patients, visitors, and staff with signs in bathrooms.
The Child Protection Program (CPP) Clinic provides medical evaluations for possible child abuse. The clinic is staffed by physicians, nurses, social workers, and advocates. During an appointment, patients provide medical history and insurance information. The CPP team then takes a history, performs a physical exam including the genital and anal areas, and may use special equipment like a colposcope. Testing and counseling referrals are provided if needed. The goal is to determine if abuse occurred and ensure children receive necessary medical care and social services.
This document provides information for patients undergoing spine surgery at UMass Memorial Spine Center. It discusses preparing for surgery, including attending an education class and presurgical evaluation. It describes what to expect during hospitalization, such as pain management and mobility. The document outlines post-surgery care like wound care, follow-up appointments, and return to daily activities and work. The goal is to help patients understand all aspects of their spine surgery and recovery.
The document discusses preparing for knee replacement surgery at UMass Memorial Medical Center. It describes the medical center's nationally recognized orthopedic program and commitment to helping patients lead active lives through high-quality care. The document provides information to help guide patients in planning for their upcoming knee replacement surgery, including classes, appointments, home and hospital preparations, the surgical process, recovery, physical therapy, and exercise guidelines.
This document provides information to help prepare a patient for total hip replacement surgery at UMass Memorial Medical Center. It discusses the hospital's nationally recognized orthopedic team. It outlines the steps patients should take before surgery, including classes, appointments, home preparations, and what to bring to the hospital. It also describes the surgical process and in-hospital recovery, including physical therapy, pain management, and preventing blood clots. The document provides guidance for at-home exercises and care after discharge.
UMass Memorial Medical Center is a leading academic medical center in Central New England committed to excellence in care, teaching, research, and community service. It offers specialized care for adults and children through specialists in its departments. The document provides information about anesthesia and pain control options for total joint replacement surgery patients at UMass Memorial, including medications before and after surgery to manage pain. It aims to inform and answer patients' questions about their surgery and recovery.
Force TJR Annual Report 2014Force TJR Annual Report 2014
Force TJR (Function and Outcomes Research for Comparative Effectiveness in Total Joint Replacement) Registry
UMass Medical School
Department of Orthopedics and Physical Rehabilitation
Force TJR QI 2014
Overview and benefits of Force TJR registry
UMassMedical School
Dr. David Ayers, Chair, UMass Memorial Orthopedics and Rehabilitation Dept.
The hospitals of UMass Memorial Health Care work with their respective communities to address identified needs of the medically underserved. Each hospital offers a number of community benefits programs that link our vast clinical and community resources to overcome barriers to accessing care and addressing health disparities. Our 2013 Community Benefits Report highlights some of these programs that meet the needs of vulnerable populations.
Check out some of the latest Showcase Ideas from across the Medical Center!
Ideas listed on the slideshow have been implemented through the department’s Idea System, and entered into the UMass Memorial Health Care Implemented Ideas Database. If you’d like to showcase your team’s idea, please email Lauren Russell.at lauren.russell@umassmemorial.org
The document describes several ideas implemented by different teams at UMass Memorial Medical Group to improve processes and patient experience.
1. The Community Medical Group created an inventory list and sign-out sheet for medicine samples to better track supplies and avoid prescription mix-ups.
2. The Clinical Integration office started providing "Idea Form Pads" at meetings so new ideas could be written down in real time to increase the number of ideas submitted.
3. The Endoscopy department implemented a process to notify patients of potential delays so they do not have to wait as long in the waiting room.
The Women’s Heart Health Program at UMass Memorial Medical Center provides cardiac care designed specifically for women.This dedicated clinic focuses on all aspects of cardiology for women, from preventive care to the treatment of complex conditions.
Our Anticoagulation Center is moving to the Hahnemann Campus July 18, 2014 We look forward to providing you the quality care you have come to trust at our new location.
This document provides 28 tips to promote heart health, including getting regular checkups, adopting a heart-healthy diet with plenty of fruits and vegetables, limiting sodium intake, exercising regularly, quitting smoking, limiting alcohol consumption, and monitoring cholesterol levels. The tips encourage maintaining a healthy lifestyle to reduce the risk of heart disease.
The Memorial Campus of our Medical Center applied for, and was awarded, a GWTG silver award for achieving the 85 percent adherence for 12 months. This award is presented by the American Heart Association.
The document describes several ideas implemented by different teams at UMass Memorial Medical Group to improve processes and patient experience.
1. The Community Medical Group created an inventory list and sign-out sheet for medicine samples to better track supplies and avoid prescription mix-ups.
2. The Clinical Integration office started providing "Idea Form Pads" at meetings so new ideas could be written down in real time to increase the number of ideas submitted.
3. The Endoscopy department implemented a process to notify patients of delays so they do not have to wait as long in the waiting room.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
1. Transcatheter Aortic Valve
Implantation
About Our Centers of Excellence — The Cancer, Diabetes, Heart
and Vascular, and Musculoskeletal Centers of Excellence deliver
seamless programs of quality and compassionate care for patients
across our health care system. Developed to meet the needs of our
community, our centers offer an experienced team approach to
specialized treatment, advanced therapies and breakthrough clinical
trials. Our highly trained physicians and staff provide patient-
centered care in modern facilities with the latest technologies as we
educate tomorrow’s health care leaders and advance science
through research at the University of Massachusetts Medical School.
Follow umassmemorial on:
TAVI Program
Heart and Vascular Center of Excellence
UMass Memorial Medical Center
55 Lake Avenue North, Worcester, MA 01655
Tel: 508-334-VALV (8258)
www.umassmemorial.org/heart
Rev 0413
MRKTG
UMassMemorial
Health Care
UMass Memorial Health Care is the largest not-for-profit health
care system in Central New England with more than 13,000
employees and nearly 2,000 physicians, many of whom are
members of UMass Memorial Medical Group. Our member
hospitals and entities include Clinton Hospital, HealthAlliance
Hospital, Marlborough Hospital, UMass Memorial Medical Center,
Wing Memorial Hospital and Medical Centers and Community
Healthlink, our behavioral health agency. With our teaching and
research partner, the University of Massachusetts Medical School,
our extensive primary care network and our Cancer, Diabetes,
Heart and Vascular, and Musculoskeletal Centers of Excellence we
deliver seamless programs of quality and compassionate care for
patients across our health care system.
UMassMemorial
Health Care
Our transcatheter aortic
valve implantation (TAVI)
program offers a possible
alternative to open heart
surgery for patients with
severe, symptomatic aortic
stenosis who are high risk
for surgery or who are
inoperable.
2. What Is Aortic Stenosis?
The aortic valve controls the flow of blood
from your heart to the rest of your body. The
normal aortic valve has three leaflets, or flaps,
which open and close. Aortic stenosis is a
narrowing of the aortic valve opening that
does not allow normal blood flow from your
heart to the rest of your body. This narrowing
causes your heart to work harder to pump
blood to the rest of the body. Left untreated,
aortic stenosis can result in complications
such as heart failure (decreased pumping
function of the heart) and death.
Aortic stenosis has several causes. It can be
caused by a birth defect, rheumatic fever,
radiation therapy or it can be age-related. In
elderly patients, the narrowing can be severe
and is often caused by a build-up of calcium
(mineral deposits).
What Are the Symptoms of Aortic
Stenosis?
The symptoms of aortic stenosis are different
for each person. Symptoms may not occur
until the narrowing of your aortic valve is
severe and may include:
• Chest pain or tightness
• Feeling faint or fainting with exertion
• Shortness of breath, especially with exertion
• Fatigue, especially during times of increased
activity
• Heart palpitations (sensations of a fast,
fluttering heartbeat)
How Is Aortic Stenosis Treated?
Treatment for aortic stenosis depends on how
far the disease has progressed. If you are
experiencing symptoms and your stenosis is
severe, your doctor may recommend open-heart
aortic valve replacement surgery. Unfortunately,
about three of every 10 patients with severe
aortic stenosis have valve medical problems that
put them at high risk for surgery or are even
inoperable. These patients may have another
option called transcatheter aortic valve
implantation (TAVI).
What Is Transcatheter Aortic Valve
Implantation (TAVI)?
TAVI is a minimally invasive option for patients
with severe, symptomatic aortic stenosis.
Approved by the Food and Drug Administration,
TAVI provides an option for patients who are at
very high risk or too sick for open-heart surgery.
TAVI is performed using general anesthesia in
specialized operating rooms. TAVI involves
making a small incision either in your leg or
chest and putting a catheter (a hollow tube) into
the artery, then guiding it into the heart. A new
heart valve is placed on a balloon catheter and
positioned inside your diseased valve. Special
imaging equipment is used to guide the
placement of the new valve. The balloon is
inflated and the new valve is implanted, opening
the narrowing and allowing blood to flow easily
to the rest of your body. The procedure will take
between three and five hours, and you can
expect to recover in the hospital for a few days
after the procedure.
About Our Treatment Program
UMass Memorial Medical Center is one of only a
few hospitals in Massachusetts offering the TAVI
procedure. Our team will carefully evaluate each
patient to determine if this minimally invasive
procedure is the best approach for you. This
ensures the best-possible outcomes – and your
peace of mind. For more information about our
TAVI program, call 508-334-VALV (8258).